Last reviewed · How we verify

NCT05493514

Clinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System

Recruiting now Last updated 9 August 2022
What this trial tests

trial testing Robotic Assisted Gait Training with G-EO system in Multiple Sclerosis in 260 participants. Currently enrolling.

Timeline
13 May 2022
Primary endpoint
1 April 2027
1 April 2027

Quick facts

Lead sponsorFondazione Don Carlo Gnocchi Onlus
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment260
Start date13 May 2022
Primary completion1 April 2027
Estimated completion1 April 2027
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Fondazione Don Carlo Gnocchi Onlus — full company profile →

Who can join

18 and older, any sex, with Multiple Sclerosis or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this work is to elaborate a statistical model to predict the effectiveness of robotic treatment in subjects with neurological diseases. The model will be used to understand which subjects are most responsive to this type of treatment

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other Fondazione Don Carlo Gnocchi Onlus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05493514.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing